Viewing Study NCT00004057


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-01-01 @ 6:56 AM
Study NCT ID: NCT00004057
Status: COMPLETED
Last Update Posted: 2013-06-21
First Post: 1999-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module